stanozolol

(1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol

LKAJKIOFIWVMDJ-IYRCEVNGSA-N CHEBI:9249 3 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

3 Reactome pathways

Metabolite details

Identifier: LKAJKIOFIWVMDJ-IYRCEVNGSA-N
InChI Key: LKAJKIOFIWVMDJ-IYRCEVNGSA-N
IUPAC name: (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
Preferred name: stanozolol
INN name: stanozolol
Synonym: Androstanazole
ChEBI: CHEBI:9249

Reactome pathways

R-HSA-2262752 - Cellular responses to stress
R-HSA-3371497 - HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
R-HSA-8953897 - Cellular responses to stimuli

Observed in studies

Observed in differential profiles